Результаты поиска - Maojin You

Enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma: a cost-effectiveness analysis from China based on the EV-302 trial по Maojin You, Qiaoyan Zheng, Ying He

Connect to this object online.

Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma по Yufan Huang, Maojin You, Qundan Wu, Ruijia Chen

Connect to this object online.

Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer по Maojin You, Ruijia Chen, Qingfeng Wu, Wei Zhu, Ying He, Yufan Huang

Connect to this object online.

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma по Ying He, Wangchun Lin, Zhongjie Cai, Yufan Huang, Maojin You, Meisheng Lei, Ruijia Chen

Connect to this object online.